As head team physician for the New York Giants, I routinely have athletes asking about supposed ‘breakthrough’ stem cell treatments,” writes Scott Rodeo.
The Utah Attorney General's office has filed charges against three people accused of performing unlicensed stem cell therapy in Draper.
Dr. Daniel Wiznia An X-ray of a femoral head (the ball at the top of the femur) that has collapsed from osteonecrosis, because of a lack of blood supply. NEW HAVEN — The hip requires a well-formed ...
Health experts are alerting travelers considering medical care abroad about a trio of recent drug-resistant bacterial infections caused by stem cell injections at Mexican clinics. After stem cell ...
Morning Overview on MSN
A stem cell sponge could absorb joint pain and shield cartilage
Osteoarthritis is one of the most expensive and disabling conditions in modern medicine, driving joint replacements and ...
SereNeuro Therapeutics revealed promising results for SN101, a first-in-class iPSC-derived therapy designed to treat chronic osteoarthritis pain while protecting joint tissue. Instead of blocking pain ...
It’s a joint venture. Longevity enthusiasts are flying around the world and spending thousands of dollars to have stem cells injected into their ailing knees. Bryan Johnson, the businessman famed for ...
Hosted on MSN
People are getting costly stem cell injections for knee osteoarthritis, but we don't know if they work
More than 500 million people around the world live with osteoarthritis. The knee is affected more often than any other joint, with symptoms (such as pain, stiffness and reduced movement) affecting ...
HealthDay on MSN
FDA Approves First Stem Cell Therapy for Severe Aplastic Anemia
The FDA has approved Omisirge (omidubicel-onlv) as the first hematopoietic stem cell transplant therapy to treat patients with SAA.
POWAY, CA, USA, August 20, 2024 /EINPresswire.com/ -- Artemis is a Bernese Mountain Dog with bilateral hip dysplasia. Hip dysplasia is a deformity of the ball and ...
Stem cell therapy is an emerging treatment for type 2 diabetes. Although it’s not yet FDA-approved in the United States, it is a rapidly expanding and promising field of research. Stem cells are ...
Samuel Whittle is supported by an Australia and New Zealand Musculoskeletal (ANZMUSC) Clinical Trial Network Practitioner Fellowship and by a grant from The Hospital Research Foundation Group. Dr ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results